Published in Trends Neurosci on October 01, 1993
Nonvesicular inhibitory neurotransmission via reversal of the GABA transporter GAT-1. Neuron (2007) 1.57
Comparative neuropharmacology of three psychostimulant cathinone derivatives: butylone, mephedrone and methylone. Br J Pharmacol (2012) 1.49
D2R DNA transfer into the nucleus accumbens attenuates cocaine self-administration in rats. Synapse (2008) 1.38
The reverse operation of Na(+)/Cl(-)-coupled neurotransmitter transporters--why amphetamines take two to tango. J Neurochem (2009) 1.36
Cone photoreceptors respond to their own glutamate release in the tiger salamander. Proc Natl Acad Sci U S A (1995) 1.29
Thinking outside the cleft to understand synaptic activity: contribution of the cystine-glutamate antiporter (System xc-) to normal and pathological glutamatergic signaling. Pharmacol Rev (2012) 1.21
Medullary serotonin neurons and their roles in central respiratory chemoreception. Respir Physiol Neurobiol (2010) 1.02
Glutamate as a neurotransmitter in the healthy brain. J Neural Transm (Vienna) (2014) 0.97
The metabotropic glutamate receptor 7 (mGluR7) allosteric agonist AMN082 modulates nucleus accumbens GABA and glutamate, but not dopamine, in rats. Neuropharmacology (2007) 0.97
Plasticity within striatal direct pathway neurons after neonatal dopamine depletion is mediated through a novel functional coupling of serotonin 5-HT2 receptors to the ERK 1/2 map kinase pathway. J Comp Neurol (2006) 0.97
Multiple gamma-Aminobutyric acid plasma membrane transporters (GAT-1, GAT-2, GAT-3) in the rat retina. J Comp Neurol (1996) 0.96
Interaction of catechol and non-catechol substrates with externally or internally facing dopamine transporters. J Neurochem (2009) 0.96
Transient expression of a novel type of GABA response in rat CA3 hippocampal neurones during development. J Physiol (1994) 0.94
Presynaptic control of serotonin on striatal dopamine function. Psychopharmacology (Berl) (2010) 0.93
N,N-dimethyl-thioamphetamine and methyl-thioamphetamine, two non-neurotoxic substrates of 5-HT transporters, have scant in vitro efficacy for the induction of transporter-mediated 5-HT release and currents. J Neurochem (2008) 0.88
Pharmacological and biochemical aspects of GABAergic neurotransmission: pathological and neuropsychobiological relationships. Cell Mol Neurobiol (2004) 0.87
Anticonvulsant enaminones depress excitatory synaptic transmission in the rat brain by enhancing extracellular GABA levels. Br J Pharmacol (2005) 0.87
Low-calcium-induced enhancement of chemical synaptic transmission from photoreceptors to horizontal cells in the vertebrate retina. Proc Natl Acad Sci U S A (1996) 0.83
Nigella sativa L. seed extract modulates the neurotransmitter amino acids release in cultured neurons in vitro. J Biomed Biotechnol (2010) 0.83
Assessment of 5-hydroxytryptamine efflux in rat brain during a mild, moderate and severe serotonin-toxicity syndrome. Eur J Pharmacol (2009) 0.82
Extracellular protons differentially potentiate the responses of native AMPA receptor subtypes regulating neurotransmitter release. Br J Pharmacol (2005) 0.81
An N-terminal threonine mutation produces an efflux-favorable, sodium-primed conformation of the human dopamine transporter. Mol Pharmacol (2014) 0.81
Inhibition by dizocilpine (MK-801) of striatal dopamine release induced by MPTP and MPP+: possible action at the dopamine transporter. Br J Pharmacol (1995) 0.79
Cysteine transport through excitatory amino acid transporter 3 (EAAT3). PLoS One (2014) 0.78
Effects of antiepileptic drugs on glutamate release from rat and human neocortical synaptosomes. Naunyn Schmiedebergs Arch Pharmacol (2011) 0.77
Dopamine release evoked by beta scorpion toxin, tityus gamma, in prefrontal cortical slices is mediated by intracellular calcium stores. Cell Mol Neurobiol (2004) 0.76
Halothane increases non-vesicular [(3)H]dopamine release from brain cortical slices. Cell Mol Neurobiol (2007) 0.76
Hippocampal betaine/GABA transporter mRNA expression is not regulated by inflammation or dehydration post-status epilepticus. J Neurochem (2011) 0.75
Role of 5-HT3 receptors in basal and K(+)-evoked dopamine release from rat olfactory tubercle and striatal slices. Br J Pharmacol (1994) 0.75
Alteration of the cardiac sympathetic innervation is modulated by duration of diabetes in female rats. Exp Diabetes Res (2011) 0.75
Transport Reversal during Heteroexchange: A Kinetic Study. J Biophys (2013) 0.75
Electrically evoked synaptosomal amino acid transmitter release in human brain in alcohol misuse. Neurosignals (2011) 0.75
Gamma-vinyl GABA increases nonvesicular release of GABA and glutamate in the nucleus accumbens in rats via action on anion channels and GABA transporters. Psychopharmacology (Berl) (2009) 0.75
Tonic GABAA Receptors as Potential Target for the Treatment of Temporal Lobe Epilepsy. Mol Neurobiol (2015) 0.75
A novel endothelial-specific membrane protein is a marker of cell-cell contacts. J Cell Biol (1992) 3.85
International Union of Pharmacology. XXXIII. Mammalian gamma-aminobutyric acid(B) receptors: structure and function. Pharmacol Rev (2002) 2.15
A simple apparatus for studying the release of neurotransmitters from synaptosomes. Eur J Pharmacol (1974) 1.91
Presynaptic kynurenate-sensitive receptors inhibit glutamate release. Eur J Neurosci (2001) 1.27
Microdialysis in Parkinsonian patient basal ganglia: acute apomorphine-induced clinical and electrophysiological effects not paralleled by changes in the release of neuroactive amino acids. Exp Neurol (2001) 1.25
Heterogeneity of presynaptic muscarinic receptors regulating neurotransmitter release in the rat brain. J Pharmacol Exp Ther (1984) 1.22
Effect of sympathomimetic amines on the synaptosomal transport of noradrenaline, dopamine and 5-hydroxytryptamine. Eur J Pharmacol (1977) 1.21
Multiple GABAB receptors. Trends Pharmacol Sci (1993) 1.21
Synaptosomes still viable after 25 years of superfusion. Neurochem Res (2000) 1.13
Dopamine can be released by two mechanisms differentially affected by the dopamine transport inhibitor nomifensine. J Pharmacol Exp Ther (1979) 1.07
Relationship between mevalonate pathway and arterial myocyte proliferation: in vitro studies with inhibitors of HMG-CoA reductase. Atherosclerosis (1993) 1.06
CGP 52432: a novel potent and selective GABAB autoreceptor antagonist in rat cerebral cortex. Eur J Pharmacol (1993) 1.05
Comparative study of the effects of mianserin, a tetracyclic antidepressant, and of imipramine on uptake and release of neurotransmitters in synaptosomes. J Pharm Pharmacol (1976) 1.03
Cholinergic terminals in rat hippocampus possess 5-HT1B receptors mediating inhibition of acetylcholine release. Eur J Pharmacol (1986) 1.03
In vivo studies of the cerebral glutamate receptor/NO/cGMP pathway. Prog Neurobiol (1999) 1.03
Detectability of high and low affinity uptake systems for GABA and glutamate in rat brain slices and synaptosomes. Life Sci I (1973) 1.03
Nerve growth factor and brain-derived neurotrophic factor increase neurotransmitter release in the rat visual cortex. Eur J Neurosci (1998) 1.03
Release and exchange studies relating to the synaptosomal uptake of GABA. J Neurochem (1975) 1.02
Serotonin release is modulated by presynaptic autoreceptors. Eur J Pharmacol (1979) 0.98
Neurochemical and autonomic pharmacological profiles of the 6-aza-analogue of mianserin, Org 3770 and its enantiomers. Neuropharmacology (1988) 0.97
Exchange of neurotransmitter amino acid at nerve endings can simulate high affinity uptake. Nature (1974) 0.96
Functional evidence for multiple gamma-aminobutyric acidB receptor subtypes in the rat cerebral cortex. J Pharmacol Exp Ther (1992) 0.96
Is there a functional linkage between neurotransmitter uptake mechanisms and presynaptic receptors? J Pharmacol Exp Ther (1984) 0.95
Pharmacologically distinct GABAB receptors that mediate inhibition of GABA and glutamate release in human neocortex. Br J Pharmacol (1997) 0.95
Interaction acetylcholine-glutamate in rat hippocampus: involvement of two subtypes of M-2 muscarinic receptors. J Pharmacol Exp Ther (1989) 0.94
d-Amphetamine as a releaser or reuptake inhibitor of biogenic amines in synaptosomes. Eur J Pharmacol (1975) 0.94
Release-enhancing glycine-dependent presynaptic NMDA receptors exist on noradrenergic terminals of hippocampus. Eur J Pharmacol (1990) 0.93
d-amphetamine and the release of 3H-norepinephrine from synaptosomes. Eur J Pharmacol (1974) 0.93
N-methyl-D-aspartic acid (NMDA) and non-NMDA receptors regulating hippocampal norepinephrine release. I. Location on axon terminals and pharmacological characterization. J Pharmacol Exp Ther (1992) 0.91
In vivo activation of N-methyl-D-aspartate receptors in the rat hippocampus increases prostaglandin E(2) extracellular levels and triggers lipid peroxidation through cyclooxygenase-mediated mechanisms. J Neurochem (2002) 0.91
Cholecystokinin release mediated by 5-HT3 receptors in rat cerebral cortex and nucleus accumbens. Br J Pharmacol (1991) 0.91
Studies on [3H]GABA and endogenous GABA release in rat cerebral cortex suggest the presence of autoreceptors of the GABAB type. Eur J Pharmacol (1987) 0.90
Modulation of the function of presynaptic alpha7 and non-alpha7 nicotinic receptors by the tryptophan metabolites, 5-hydroxyindole and kynurenate in mouse brain. Br J Pharmacol (2006) 0.90
Muscarinic inhibition of endogenous glutamate release from rat hippocampus synaptosomes. Neurosci Lett (1989) 0.89
Pathogenesis of atherosclerosis and the role of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors. Am J Cardiol (1995) 0.89
GABA(B) receptor antagonists elevate both mRNA and protein levels of the neurotrophins nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) but not neurotrophin-3 (NT-3) in brain and spinal cord of rats. Neuropharmacology (2000) 0.89
Serotonin autoreceptor in rat hippocampus: pharmacological characterization as a subtype of the 5-HT1 receptor. Naunyn Schmiedebergs Arch Pharmacol (1986) 0.89
On the presence in the cerebral cortex of muscarinic receptor subtypes which differ in neuronal localization, function and pharmacological properties. J Pharmacol Exp Ther (1985) 0.89
Presynaptic alpha 2-adrenoceptors mediating inhibition of noradrenaline and 5-hydroxytryptamine release in rat cerebral cortex: further characterization as different alpha 2-adrenoceptor subtypes. Naunyn Schmiedebergs Arch Pharmacol (1992) 0.88
Regional differences in the synaptosomal uptake of 3H-gamma-aminobutyric acid and 14C-glutamate and possible role of exchange processes. J Pharmacol Exp Ther (1974) 0.87
Evidence for functional native NMDA receptors activated by glycine or D-serine alone in the absence of glutamatergic coagonist. Eur J Neurosci (1998) 0.87
Glutamate release in human cerebral cortex and its modulation by 5-hydroxytryptamine acting at h 5-HT1D receptors. Br J Pharmacol (1998) 0.87
Studies on dopamine uptake and release in synaptosomes. Adv Biochem Psychopharmacol (1978) 0.87
gamma-Aminobutyric acid (GABA) autoreceptors in rat cerebral cortex and spinal cord represent pharmacologically distinct subtypes of the GABAB receptor. J Pharmacol Exp Ther (1993) 0.87
Phaclofen antagonizes GABA at autoreceptors regulating release in rat cerebral cortex. Eur J Pharmacol (1988) 0.86
Alpha 2-adrenoceptors in rat hypothalamus and cerebral cortex: functional evidence for pharmacologically distinct subpopulations. Eur J Pharmacol (1985) 0.86
A reevaluation of veratridine as a tool for studying the depolarization-induced release of neurotransmitters from nerve endings. Neurochem Res (1980) 0.86
Nicotine administration stimulates the in vivo N-methyl-D-aspartate receptor/nitric oxide/cyclic GMP pathway in rat hippocampus through glutamate release. Br J Pharmacol (1998) 0.86
Effects of 26-aminocholesterol, 27-hydroxycholesterol, and 25-hydroxycholesterol on proliferation and cholesterol homeostasis in arterial myocytes. Arterioscler Thromb Vasc Biol (1995) 0.86
Effect of the new calcium antagonist lercanidipine and its enantiomers on the migration and proliferation of arterial myocytes. J Cardiovasc Pharmacol (1996) 0.86
Characterization of the GABA autoreceptor in human neocortex as a pharmacological subtype of the GABAB receptor. Eur J Pharmacol (1994) 0.85
Extracellular cGMP in the hippocampus of freely moving rats as an index of nitric oxide (NO) synthase activity. J Neurosci (1994) 0.85
Effect of desmethylimipramine on the release of (3H)norepinephrine induced by various agents in hypothalamic synaptosomes. Mol Pharmacol (1977) 0.85
GABA and glutamate uptake by subcellular fractions enriched in synaptosomes: critical evaluation of some methodological aspects. Brain Res (1973) 0.85
Differential antagonism by dicyclomine, pirenzepine and secoverine at muscarinic receptor subtypes in the rat frontal cortex. Eur J Pharmacol (1985) 0.85
(-)-Propranolol and (+/-)-cyanopindolol are mixed agonists-antagonists at serotonin autoreceptors in the hippocampus of the rat brain. Neuropharmacology (1987) 0.84
GABAergic nerve terminals in rat hippocampus possess alpha 2-adrenoceptors regulating GABA release. Neurosci Lett (1987) 0.84
Functional interactions between presynaptic NMDA receptors and metabotropic glutamate receptors co-expressed on rat and human noradrenergic terminals. Br J Pharmacol (2007) 0.84
Release-regulating serotonin 5-HT1D autoreceptors in human cerebral cortex. J Neurochem (1993) 0.84
Monitoring of cyclic GMP during cerebellar microdialysis in freely-moving rats as an index of nitric oxide synthase activity. Neuroscience (1993) 0.83
Functional evidence for two stereochemically different alpha-2 adrenoceptors regulating central norepinephrine and serotonin release. J Pharmacol Exp Ther (1983) 0.83
Differential pharmacology and function of two 5-HT1 receptors modulating transmitter release in rat cerebellum. J Pharmacol Exp Ther (1986) 0.83
In vivo microdialysis study of a specific inhibitor of soluble guanylyl cyclase on the glutamate receptor/nitric oxide/cyclic GMP pathway. Br J Pharmacol (1996) 0.83
Synaptosomal transport processes. Int Rev Neurobiol (1976) 0.83
Deep brain stimulation in Parkinson's disease patients: biochemical evidence. J Neural Transm Suppl (2006) 0.83
Release-regulating presynaptic heterocarriers. Prog Neurobiol (1994) 0.82
Renal transplantation in Alport's syndrome. Personal experience in twelve patients. Contrib Nephrol (1990) 0.82
Differential desensitization of ionotropic non-NMDA receptors having distinct neuronal location and function. Naunyn Schmiedebergs Arch Pharmacol (1997) 0.82
Presynaptic muscarinic receptors increase striatal dopamine release evoked by "quashi-physiological" depolarization. Eur J Pharmacol (1982) 0.82
Age-related changes in the NMDA receptor/nitric oxide/cGMP pathway in the hippocampus and cerebellum of freely moving rats subjected to transcerebral microdialysis. Eur J Neurosci (1995) 0.82
Enhancement of glycine release from human brain cortex synaptosomes by acetylcholine acting at M4 muscarinic receptors. J Pharmacol Exp Ther (1993) 0.82
In vivo microdialysis study of GABA(A) and GABA(B) receptors modulating the glutamate receptor/NO/cyclic GMP pathway in the rat hippocampus. Neuropharmacology (1997) 0.82
Gp120 can revert antagonism at the glycine site of NMDA receptors mediating GABA release from cultured hippocampal neurons. J Neurosci Res (1997) 0.82
The human immunodeficiency virus-1 envelope protein gp120 binds through its V3 sequence to the glycine site of N-methyl-D-aspartate receptors mediating noradrenaline release in the hippocampus. Neuroscience (1998) 0.81
The "kynurenate test", a biochemical assay for putative cognition enhancers. J Pharmacol Exp Ther (1997) 0.81
Chronic drug treatments induce changes in the sensitivity of presynaptic autoreceptors but not of presynaptic heteroreceptors. Eur J Pharmacol (1983) 0.81
Native human neocortex release-regulating dopamine D2 type autoreceptors are dopamine D2 subtype. Eur J Neurosci (1999) 0.81
GABA induces norepinephrine exocytosis from hippocampal noradrenergic axon terminals by a dual mechanism involving different voltage-sensitive calcium channels. J Neurosci Res (1999) 0.81
Age-related decrease of the NMDA receptor-mediated noradrenaline release in rat hippocampus and partial restoration by D-cycloserine. Eur J Pharmacol (1993) 0.81
Pharmacological discrimination between gamma-aminobutyric acid type B receptors regulating cholecystokinin and somatostatin release from rat neocortex synaptosomes. Mol Pharmacol (1994) 0.81
The HIV-1 coat protein gp120 and some of its fragments potently activate native cerebral NMDA receptors mediating neuropeptide release. Eur J Neurosci (2000) 0.81
Human brain N-methyl-D-aspartate receptors regulating noradrenaline release are positively modulated by HIV-1 coat protein gp120. AIDS (1996) 0.81
Do presynaptic autoreceptors control dopamine release? Nature (1978) 0.81
Release-regulating autoreceptors of the GABAB-type in human cerebral cortex. Br J Pharmacol (1989) 0.81
Endothelial integrins and their role in maintaining the integrity of the vessel wall. Kidney Int (1993) 0.81
Color Doppler imaging study in patients with primary open-angle glaucoma treated with timolol 0.5% and carteolol 2%. Eur J Ophthalmol (2001) 0.80
Release-regulating D-2 dopamine receptors are located on striatal glutamatergic nerve terminals. J Pharmacol Exp Ther (1988) 0.80
Enhanced benzodiazepine and ethanol actions on cerebellar GABA(A) receptors mediating glutamate release in an alcohol-sensitive rat line. Neuropharmacology (1999) 0.80
Effects of phenethylamine derivatives on the release of biogenic amines from synaptosomes. Biochem Soc Trans (1976) 0.80
5-Hydroxytryptamine3 receptors sited on cholinergic axon terminals of human cerebral cortex mediate inhibition of acetylcholine release. J Neurochem (1992) 0.80
gamma-Aminobutyric acidB receptors mediate inhibition of somatostatin release from cerebrocortex nerve terminals. J Pharmacol Exp Ther (1991) 0.80
Effect of the new HMG-CoA reductase inhibitor cerivastatin (BAY W 6228)on migration, proliferation and cholesterol synthesis in arterial myocytes. Pharmacol Res (1996) 0.80
Transmitter release associated with long-term synaptic depression in rat corticostriatal slices. Eur J Neurosci (1995) 0.80
Benzodiazepine-sensitive GABA(A) receptors limit the activity of the NMDA/NO/cyclic GMP pathway: a microdialysis study in the cerebellum of freely moving rats. J Neurochem (2000) 0.80
Enhancement of endogenous GABA release from rat synaptosomal preparations is mediated by alpha 2-adrenoceptors pharmacologically different from alpha 2-autoreceptors. Eur J Pharmacol (1988) 0.80
Use of a newly developed ultrasound contrast medium for color Doppler evaluation in kidney transplantation. Transplant Proc (1999) 0.79
Uptake and exchange of GABA and glutamate in isolated nerve endings. Adv Exp Med Biol (1976) 0.79
Stereochemical interpretation of high oxygen affinity of haemoglobin Little Rock alpha-2beta-2 143His-Gln. Nat New Biol (1973) 0.79
Dopamine biosynthesis is regulated by the amine newly recaptured by dopaminergic nerve endings. Eur J Pharmacol (1980) 0.79